A carregar...
Opinion: miRNAs – The new wave of molecular cancer therapeutics
Cutting-edge advances in nanomedicine and the recent approval of two siRNA-based therapeutics by the Food and Drug Administration (FDA) has rekindled the interest in RNA interference (RNAi) as vehicles for the development of novel cancer therapeutics. In this perspective, we will briefly discuss how...
Na minha lista:
| Publicado no: | Transl Oncol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Neoplasia Press
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7957095/ https://ncbi.nlm.nih.gov/pubmed/33721829 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2021.101064 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|